|
|
||||||||||
|
J Am Coll Cardiol, 2000; 35:1628-1637 © 2000 by the American College of Cardiology Foundation |





* Division of Cardiology, Georgetown University Hospital, Washington, DC, USA
j St. Francis Hospital, Roslyn, New York, USA
Department of Biostatistics, Washington University, Seattle, Washington, USA
Division of Cardiology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA
Department of Radiology, TuftsNew England Medical Center, Boston, Massachusetts, USA
|| Colchester Research Facility, University of Vermont, Colchester, Vermont, USA
¶ Wake Forest University, Winston-Salem, North Carolina, USA
# University of California at Irvine, Irvine, California, USA
** Division of Cardiovascular Medicine, University of California at Davis, Davis, California, USA

Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
Manuscript received April 2, 1999; revised manuscript received December 7, 1999, accepted January 19, 2000.
Reprint requests and correspondence: Dr. John S. Gottdiener, Cardiology Research, St. Francis Hospital, 100 Port Washington Boulevard, Roslyn, New York 11576
gottdien{at}ziplink.net
OBJECTIVES
We sought to characterize the predictors of incident congestive heart failure (CHF), as determined by central adjudication, in a community-based elderly population.
BACKGROUND
The elderly constitute a growing proportion of patients admitted to the hospital with CHF, and CHF is a leading source of morbidity and mortality in this group. Elderly patients differ from younger individuals diagnosed with CHF in terms of biologic characteristics.
METHODS
We analyzed data from the Cardiovascular Health Study, a prospective population-based study of 5,888 elderly people >65 years old (average 73 ± 5, range 65 to 100) at four locations. Multiple laboratory measures of cardiovascular structure and function, blood chemistries and functional assessments were obtained.
RESULTS
During an average follow-up of 5.5 years (median 6.3), 597 participants developed incident CHF (rate 19.3/1,000 person-years). The incidence of CHF increased progressively across age groups and was greater in men than in women. On multivariate analysis, other independent predictors included prevalent coronary heart disease, stroke or transient ischemic attack at baseline, diabetes, systolic blood pressure (BP), forced expiratory volume 1 s, creatinine >1.4 mg/dl, C-reactive protein, ankle-arm index <0.9, atrial fibrillation, electrocardiographic (ECG) left ventricular (LV) mass, ECG ST-T segment abnormality, internal carotid artery wall thickness and decreased LV systolic function. Population-attributable risk, determined from predictors of risk and prevalence, was relatively high for prevalent coronary heart disease (13.1%), systolic BP
140 mm Hg (12.8%) and a high level of C-reactive protein (9.7%), but was low for subnormal LV function (4.1%) and atrial fibrillation (2.2%).
CONCLUSIONS
The incidence of CHF is high in the elderly and is related mainly to age, gender, clinical and subclinical coronary heart disease, systolic BP and inflammation. Despite the high relative risk of subnormal systolic LV function and atrial fibrillation, the actual population risk of these for CHF is small because of their relatively low prevalence in community-dwelling elderly people.
| ||||||||||||||||||
This article has been cited by other articles:
![]() |
R. Pini, M. C. Cavallini, V. Palmieri, N. Marchionni, M. Di Bari, R. B. Devereux, G. Masotti, and M. J. Roman Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2432 - 2439. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bahrami, D. A. Bluemke, R. Kronmal, A. G. Bertoni, D. M. Lloyd-Jones, E. Shahar, M. Szklo, and J. A.C. Lima Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1775 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. MacDonald, M. C. Petrie, N. M. Hawkins, J. R. Petrie, M. Fisher, R. McKelvie, D. Aguilar, H. Krum, and J. J.V. McMurray Diabetes, left ventricular systolic dysfunction, and chronic heart failure Eur. Heart J., May 2, 2008; 29(10): 1224 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Marwick Diabetic heart disease Postgrad. Med. J., April 1, 2008; 84(990): 188 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. de Simone, J. S. Gottdiener, M. Chinali, and M. S. Maurer Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur. Heart J., March 2, 2008; 29(6): 741 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ix, R. Katz, B. Kestenbaum, L. F. Fried, H. Kramer, C. Stehman-Breen, and M. G. Shlipak Association of Mild to Moderate Kidney Dysfunction and Coronary Calcification J. Am. Soc. Nephrol., March 1, 2008; 19(3): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kazory and E. A. Ross Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective Circulation, February 19, 2008; 117(7): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition Eur. Heart J., February 1, 2008; 29(3): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gurven, H. Kaplan, J. Winking, C. Finch, and E. M. Crimmins Aging and Inflammation in Two Epidemiological Worlds J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 196 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Lee, J. M. Massaro, T. J. Wang, W. B. Kannel, E. J. Benjamin, S. Kenchaiah, D. Levy, R. B. D'Agostino Sr, and R. S. Vasan Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life Hypertension, November 1, 2007; 50(5): 869 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients Ann Intern Med, September 4, 2007; 147(5): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Owens and J. F. Plehn Recognizing Unrecognized Risk: The Evolving Role of Ventricular Functional Assessment in Population-Based Studies Circulation, July 10, 2007; 116(2): 126 - 130. [Full Text] [PDF] |
||||
![]() |
A. Kottgen, S. D. Russell, L. R. Loehr, C. M. Crainiceanu, W. D. Rosamond, P. P. Chang, L. E. Chambless, and J. Coresh Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1307 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sabatine, D. A. Morrow, K. A. Jablonski, M. M. Rice, J. W. Warnica, M. J. Domanski, J. Hsia, B. J. Gersh, N. Rifai, P. M Ridker, et al. Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease Circulation, March 27, 2007; 115(12): 1528 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Petrie and J. J.V. McMurray Dysglycemia and Heart Failure Hospitalization: What Is the Link? Circulation, March 20, 2007; 115(11): 1334 - 1335. [Full Text] [PDF] |
||||
![]() |
V. H. Huxley Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently Advan Physiol Educ, March 1, 2007; 31(1): 17 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Rosen, M. Cushman, K. Nasir, D. A. Bluemke, T. Edvardsen, V. Fernandes, S. Lai, R. P. Tracy, and J. A.C. Lima Relationship Between C-Reactive Protein Levels and Regional Left Ventricular Function in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis J. Am. Coll. Cardiol., February 6, 2007; 49(5): 594 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schaufelberger and A. Rosengren Heart failure in different occupational classes in Sweden Eur. Heart J., January 2, 2007; 28(2): 212 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Shlipak, R. Katz, M. J. Sarnak, L. F. Fried, A. B. Newman, C. Stehman-Breen, S. L. Seliger, B. Kestenbaum, B. Psaty, R. P. Tracy, et al. Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease Ann Intern Med, August 15, 2006; 145(4): 237 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bibbins-Domingo, G. M. Chertow, L. F. Fried, M. C. Odden, A. B. Newman, S. B. Kritchevsky, T. B. Harris, S. Satterfield, S. R. Cummings, and M. G. Shlipak Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study. Arch Intern Med, July 10, 2006; 166(13): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingelsson, K. Bjorklund-Bodegard, L. Lind, J. Arnlov, and J. Sundstrom Diurnal blood pressure pattern and risk of congestive heart failure. JAMA, June 28, 2006; 295(24): 2859 - 2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R.S. Fernandes, J. F. Polak, T. Edvardsen, B. Carvalho, A. Gomes, D. A. Bluemke, K. Nasir, D. H. O'Leary, and J. A.C. Lima Subclinical Atherosclerosis and Incipient Regional Myocardial Dysfunction in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis (MESA) J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2420 - 2428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bertoni, D. C. Goff Jr, R. B. D'Agostino Jr, K. Liu, W. G. Hundley, J. A. Lima, J. F. Polak, M. F. Saad, M. Szklo, R. P. Tracy, et al. Diabetic Cardiomyopathy and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care, March 1, 2006; 29(3): 588 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
T H Marwick Diabetic heart disease Heart, March 1, 2006; 92(3): 296 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Kuller, A. M. Arnold, B. M. Psaty, J. A. Robbins, D. H. O'Leary, R. P. Tracy, G. L. Burke, T. A. Manolio, and P. H. M. Chaves 10-Year Follow-up of Subclinical Cardiovascular Disease and Risk of Coronary Heart Disease in the Cardiovascular Health Study Arch Intern Med, January 9, 2006; 166(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, M. S. Nieminen, S. Jern, L. Oikarinen, M. Viitasalo, L. Toivonen, S. E. Kjeldsen, B. Dahlof, and for the LIFE Study Investigators Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Circulation, January 3, 2006; 113(1): 67 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Valle, E. Bagolin, C. Canali, P. Giovinazzo, S. Barro, N. Aspromonte, E. Carbonieri, and L. Milani The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients Eur J Echocardiogr, January 1, 2006; 7(1): 40 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rodondi, A. B. Newman, E. Vittinghoff, N. de Rekeneire, S. Satterfield, T. B. Harris, and D. C. Bauer Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death Arch Intern Med, November 28, 2005; 165(21): 2460 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Anand, R. Latini, V. G. Florea, M. A. Kuskowski, T. Rector, S. Masson, S. Signorini, P. Mocarelli, A. Hester, R. Glazer, et al. C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan Circulation, September 6, 2005; 112(10): 1428 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Doobay and S. S. Anand Sensitivity and Specificity of the Ankle-Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1463 - 1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian, C. L. Bryson, R. N. Lemaitre, G. L. Burke, and D. S. Siscovick Fish Intake and Risk of Incident Heart Failure J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2015 - 2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sarnak, R. Katz, C. O. Stehman-Breen, L. F. Fried, N. S. Jenny, B. M. Psaty, A. B. Newman, D. Siscovick, M. G. Shlipak, and and the Cardiovascular Health Study* Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults Ann Intern Med, April 5, 2005; 142(7): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Smith, M. G. Shlipak, E. P. Havranek, F. A. Masoudi, W. M. McClellan, J. M. Foody, S. S. Rathore, and H. M. Krumholz Race and Renal Impairment in Heart Failure: Mortality in Blacks Versus Whites Circulation, March 15, 2005; 111(10): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Arias, A. Alonso, F. Garcia-Rio, G. P. Aurigemma, and W. H. Gaasch Diastolic Heart Failure N. Engl. J. Med., January 20, 2005; 352(3): 307 - 308. [Full Text] [PDF] |
||||
![]() |
D. J. Campbell, M. Woodward, J. P. Chalmers, S. A. Colman, A. J. Jenkins, B. E. Kemp, B. C. Neal, A. Patel, and S. W. MacMahon Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease Hypertension, January 1, 2005; 45(1): 69 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Arnlov, E. Ingelsson, U. Riserus, B. Andren, and L. Lind Myocardial performance index, a Doppler-derived index of global left ventricular function, predicts congestive heart failure in elderly men Eur. Heart J., December 2, 2004; 25(24): 2220 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gardin and M. S. Lauer Left Ventricular Hypertrophy: The Next Treatable, Silent Killer? JAMA, November 17, 2004; 292(19): 2396 - 2398. [Full Text] [PDF] |
||||
![]() |
G. D. Schellenbaum, T. D. Rea, S. R. Heckbert, N. L. Smith, T. Lumley, V. L. Roger, D. W. Kitzman, H. A. Taylor, D. Levy, and B. M. Psaty Survival Associated with Two Sets of Diagnostic Criteria for Congestive Heart Failure Am. J. Epidemiol., October 1, 2004; 160(7): 628 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Aurigemma and W. H. Gaasch Diastolic Heart Failure N. Engl. J. Med., September 9, 2004; 351(11): 1097 - 1105. [Full Text] [PDF] |
||||
![]() |
G. S. Bleumink, A. M. Knetsch, M. C.J.M. Sturkenboom, S. M.J.M. Straus, A. Hofman, J. W. Deckers, J. C.M. Witteman, and B. H.Ch. Stricker Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study Eur. Heart J., September 2, 2004; 25(18): 1614 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Nichols, C. M. Gullion, C. E. Koro, S. A. Ephross, and J. B. Brown The Incidence of Congestive Heart Failure in Type 2 Diabetes: An update Diabetes Care, August 1, 2004; 27(8): 1879 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Drazner, J. E. Rame, E. K. Marino, J. S. Gottdiener, D. W. Kitzman, J. M. Gardin, T. A. Manolio, D. L. Dries, and D. S. Siscovick Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: The Cardiovascular Health Study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2207 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Barzilay, R. A. Kronmal, J. S. Gottdiener, N. L. Smith, G. L. Burke, R. Tracy, P. J. Savage, and M. Carlson The association of fasting glucose levels with congestive heart failure in diabetic adults >=65 years: The Cardiovascular Health Study J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2236 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
F A McAlister, N F Murphy, C R Simpson, S Stewart, K MacIntyre, M Kirkpatrick, J Chalmers, A Redpath, S Capewell, and J J V McMurray Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study BMJ, May 8, 2004; 328(7448): 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jessup and I. L. Pina Is it important to examine gender differences in the epidemiology and outcome of severe heart failure? J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1247 - 1252. [Full Text] [PDF] |
||||
![]() |
A. G. Bertoni, W. G. Hundley, M. W. Massing, D. E. Bonds, G. L. Burke, and D. C. Goff Jr. Heart Failure Prevalence, Incidence, and Mortality in the Elderly With Diabetes Diabetes Care, March 1, 2004; 27(3): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension, November 1, 2003; 42(5): 1050 - 1065. [Full Text] [PDF] |
||||
![]() |
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation, October 28, 2003; 108(17): 2154 - 2169. [Full Text] [PDF] |
||||
![]() |
D. Johnson, Y. Jin, H. Quan, and B. Cujec Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1438 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Massie Natriuretic peptide measurements for the diagnosis of "nonsystolic" heart failure: Good news and bad J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2018 - 2021. [Full Text] [PDF] |
||||
![]() |
L. F. Fried, M. G. Shlipak, C. Crump, A. J. Bleyer, J. S. Gottdiener, R. A. Kronmal, L. H. Kuller, and A. B. Newman Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1364 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention Circulation, March 4, 2003; 107(8): 1210 - 1225. [Full Text] [PDF] |
||||
![]() |
E. Vittinghoff, M. G. Shlipak, P. D. Varosy, C. D. Furberg, C. C. Ireland, S. S. Khan, R. Blumenthal, E. Barrett-Connor, S. Hulley, and for the Heart and Estrogen/progestin Replacement S Risk Factors and Secondary Prevention in Women with Heart Disease: The Heart and Estrogen/progestin Replacement Study Ann Intern Med, January 21, 2003; 138(2): 81 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Henriksen and D E Newby Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart Heart, January 1, 2003; 89(1): 14 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Kitzman, W. C. Little, P. H. Brubaker, R. T. Anderson, W. G. Hundley, C. T. Marburger, B. Brosnihan, T. M. Morgan, and K. P. Stewart Pathophysiological Characterization of Isolated Diastolic Heart Failure in Comparison to Systolic Heart Failure JAMA, November  |